Physician profile
Michael W Wandling
NPI 1447546783
$24,781.01
in general payments reported to CMS, 2019-2025
7 companies · $9,074 in 2025
The $9,074 reported for 2025 was more than what 95% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $123 · 2021: $33.65 · 2022: $490 · 2023: $164 · 2024: $15K · 2025: $9,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $3,180 · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,950.00 |
| Travel and Lodging | $3,179.74 |
| Food and Beverage | $1,004.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $23,760.97 | 2021-2025 | Renasys Touch, Grafix, Pico |
| Teleflex LLC | $330.68 | 2022 | |
| Davol INC. | $276.67 | 2022-2024 | Phasix Mesh |
| Mesh Suture INC | $129.37 | 2024 | |
| Abbvie INC. | $123.73 | 2023 | Alloderm |
| Depuy Synthes Sales INC. | $123.00 | 2020 | |
| Tela Bio, INC. | $36.59 | 2021-2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wandling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.